ArticleOncotarget2018
Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition.
Douglas Spaeth-Cook et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleOncotarget2018
Douglas Spaeth-Cook et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.